Renalytix Plc (AIM:RENX)
5.87
-0.28 (-4.55%)
Sep 25, 2026, 4:27 PM GMT
Renalytix Revenue
Renalytix had revenue of $800.00K USD in the quarter ending December 31, 2025, with 36.52% growth. This brings the company's revenue in the last twelve months to $3.30M, up 40.31% year-over-year. In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M with 30.43% growth.
Revenue (ttm)
$3.30M
Revenue Growth
+40.31%
P/S Ratio
15.15
Revenue / Employee
$71.74K
Employees
46
Market Cap
37.14M GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.00M | 700.00K | 30.43% |
| Jun 30, 2024 | 2.30M | -1.10M | -32.41% |
| Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
| Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
| Jun 30, 2021 | 1.49M | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Craneware | 155.23M |
| Optima Health | 120.64M |
| Diaceutics | 41.33M |
| Cambridge Cognition Holdings | 10.13M |
| Feedback | 849.62K |
| Imaging Biometrics | 810.42K |
| Trellus Health | 262.03K |
Renalytix News
- 2 months ago - KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists - PRNewsWire
- 4 months ago - Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention - PRNewsWire
- 6 months ago - Renalytix Quarterly report: H1 2026 - Filings
- 7 months ago - Renalytix Earnings release: H1 2026 - Filings
- 10 months ago - Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes - PRNewsWire
- 10 months ago - Renalytix Annual report: Q4 2025 - Filings
- 1 year ago - Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease - PRNewsWire
- 1 year ago - MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities - PRNewsWire